{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:06:13Z","timestamp":1787792773398,"version":"build-2784847793"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Hum. Neurosci."],"abstract":"<jats:p>Emerging evidence suggests that striatal striosomes play a key role in the dopaminergic regulation of motor and mental action selection processes, with impairments leading to repetitive stereotyped movements (dystonias), thoughts (obsessions), and behaviors (compulsions). To explore this hypothesis therapeutically, we investigated how idiopathic dystonia and obsessive-compulsive disorder (OCD) respond to a novel dopaminergic treatment using low-dose L-DOPA combined with chlorpromazine (CPZ), which can primarily enhance striosomal D<jats:sub>1<\/jats:sub> dopamine receptor (D<jats:sub>1<\/jats:sub>R) signaling in humans. The therapeutic effects of L-DOPA\/CPZ were assessed over 1 year in 26 idiopathic dystonia patients (mean age, 55.9 years; 23.1% male) with OCD. The daily doses of L-DOPA\/carbidopa and CPZ-phenolphthalinate were increased stepwise to 50 mg and 5 mg, respectively, three times daily over an 8-weeks period, and then maintained for a year. The severity of dystonia and OCD was evaluated using the Burke-Fahn-Marsden Dystonia Movement Scale (BFMDMS) and Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). At a 1-year follow-up, the BFMDMS and Y-BOCS scores improved by approximately 80% (mean difference, \u221213.8; 95% CI, \u221216.9 to \u221210.6; <jats:italic>P<\/jats:italic> &amp;lt; 0.0001) and 75% (mean difference, \u221216.0; 95% CI, \u221216.1 to \u221215.8; <jats:italic>P<\/jats:italic> &amp;lt; 0.0001), respectively, with no specific adverse effects. Thus, low-dose L-DOPA\/CPZ provided striking and lasting benefits to patients with idiopathic dystonia and OCD. Our findings indicate that dystonia and OCD may share a common striatal dysfunction due to altered D<jats:sub>1<\/jats:sub>R signaling in the striosomes. Pharmacologic interventions aimed at modulating striosomal D<jats:sub>1<\/jats:sub>R signaling could enhance our understanding of the striatal mechanisms involved in the pathophysiology of both dystonia and OCD.<\/jats:p>","DOI":"10.3389\/fnhum.2025.1621054","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T05:34:46Z","timestamp":1755668086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic effects of striatal dopaminergic modulation on idiopathic dystonia and OCD in humans: insights from the striosome hypothesis"],"prefix":"10.3389","volume":"19","author":[{"given":"Shinichi","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: A consensus update.","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex.","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu. Rev. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnhum.2011.00047","article-title":"Shifting responsibly: The importance of striatal modularity to reinforcement learning in uncertain environments.","volume":"5","author":"Amemori","year":"2011","journal-title":"Front. Hum. Neurosci."},{"key":"B4","year":"2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5."},{"key":"B5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/mdc3.12211","article-title":"Nonmotor symptoms in dopa-responsive dystonia.","volume":"2","author":"Antelmi","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","article-title":"Dystonia.","volume":"4","author":"Balint","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/mds.23906","article-title":"Obsessive-compulsive symptoms in primary focal dystonia: A controlled study.","volume":"26","author":"Barahona-Corr\u00eaa","year":"2011","journal-title":"Mov. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.euroneuro.2019.06.006","article-title":"A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD.","volume":"29","author":"Biria","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1212\/wnl.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias.","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/s0006-3223(02)01332-x","article-title":"Obsessive compulsive disorder among idiopathic focal dystonia patients: An epidemiological and family study.","volume":"52","author":"Cavallaro","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1038\/s41467-023-41130-y","article-title":"Dopamine regulates decision thresholds in human reinforcement learning in males.","volume":"14","author":"Chakroun","year":"2023","journal-title":"Nat. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107583","DOI":"10.1016\/j.pharmthera.2020.107583","article-title":"Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.","volume":"213","author":"Chen","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/ejn.15116","article-title":"Striatal transcriptome changes linked to drug-induced repetitive behaviors.","volume":"53","author":"Crittenden","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnana.2011.00059","article-title":"Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.","volume":"5","author":"Crittenden","year":"2011","journal-title":"Front Neuroanat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The yale-brown obsessive compulsive scale. I. Development, use, and reliability.","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1178616","DOI":"10.3389\/fnhum.2023.1178616","article-title":"Specificity of striatal dopamine D1 system in humans: implications for clinical use of D1 receptor-agonists in Parkinson\u2019s disease.","volume":"17","author":"Goto","year":"2023","journal-title":"Front. Hum. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/jnnp-2024-334545","article-title":"Functional pathology of neuroleptic-induced dystonia based on the striatal striosome-matrix dopamine system in humans.","volume":"96","author":"Goto","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-neuro-121522-025740","article-title":"Striosomes and matrisomes: Scaffolds for dynamic coupling of volition and action.","volume":"46","author":"Graybiel","year":"2023","journal-title":"Annu. Rev. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ajmg.b.30431","article-title":"Obsessive-compulsive disorder is not a clinical manifestation of the DYT1 dystonia gene.","author":"Heiman","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41593-024-01570-1","article-title":"Mapping dysfunctional circuits in the frontal cortex using deep brain stimulation.","volume":"27","author":"Hollunder","year":"2024","journal-title":"Nat. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1124\/jpet.118.247981","article-title":"Dopamine D2 receptor supersensitivity as a spectrum of neurotoxicity and status in psychiatric disorders.","volume":"366","author":"Kostrzewa","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(02)11339-0","article-title":"Compulsions, Parkinson\u2019s disease, and stimulation.","volume":"360","author":"Mallet","year":"2002","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.14802\/jmd.23265","article-title":"Meige syndrome as a craniofacial type of dystonia treatable by dual dopaminergic modulation using L-DOPA\/Chlorpromazine: A case report.","volume":"17","author":"Matsumoto","year":"2024","journal-title":"J. Mov. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e200254","DOI":"10.1212\/CPJ.0000000000200254","article-title":"Therapeutic effects of dual dopaminergic modulation with l-DOPA and chlorpromazine in patients with idiopathic cervical dystonia.","volume":"14","author":"Matsumoto","year":"2024","journal-title":"Neurol Clin. Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fneur.2022.922333","article-title":"A dual dopaminergic therapy with L-3,4-dihydroxyphenylalanine and chlorpromazine for the treatment of blepharospasm, a focal dystonia: Possible implications for striosomal D1 signaling.","volume":"13","author":"Matsumoto","year":"2022","journal-title":"Front. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/7854_2020_204","article-title":"Pharmacotherapeutic strategies and new targets in OCD.","volume":"49","author":"Pittenger","year":"2021","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/B978-0-12-819410-2.00011-4","article-title":"Plasticity, genetics and epigenetics in dystonia: An update.","volume":"184","author":"Sciamanna","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1017\/S146114571200154X","article-title":"Evaluation of animal models of obsessive-compulsive disorder: Correlation with phasic dopamine neuron activity.","volume":"16","author":"Sesia","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e48960","DOI":"10.7759\/cureus.48960","article-title":"Obsessive-Compulsive Disorder (OCD): A comprehensive review of diagnosis, comorbidities, and treatment approaches.","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"B30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","article-title":"Obsessive-compulsive disorder.","volume":"5","author":"Stein","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.015","article-title":"Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes.","volume":"69","author":"Timmers","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"152352","DOI":"10.1016\/j.comppsych.2022.152352","article-title":"Treatment-resistant OCD: Pharmacotherapies in adults.","volume":"120","author":"van Roessel","year":"2023","journal-title":"Compr. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1002\/mds.23250","article-title":"Psychiatric symptoms associated with focal hand dystonia.","volume":"25","author":"Voon","year":"2010","journal-title":"Mov. Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: Clues from an in vivo neurochemistry study with PET.","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s11571-022-09858-3","article-title":"A computational network dynamical modeling for abnormal oscillation and deep brain stimulation control of obsessive-compulsive disorder.","volume":"17","author":"Yin","year":"2023","journal-title":"Cogn. Neurodyn."},{"key":"B36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41593-023-01390-9","article-title":"Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons.","volume":"26","author":"Yun","year":"2023","journal-title":"Nat. Neurosci."}],"container-title":["Frontiers in Human Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1621054\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T05:34:48Z","timestamp":1755668088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1621054\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":36,"alternative-id":["10.3389\/fnhum.2025.1621054"],"URL":"https:\/\/doi.org\/10.3389\/fnhum.2025.1621054","relation":{},"ISSN":["1662-5161"],"issn-type":[{"value":"1662-5161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"article-number":"1621054"}}